Key facts
- IgniteData’s last known valuation is $71.0M (Oct 2025).
- It has raised $16.0M; the latest was Later Stage VC ($11.0M) in Oct 2025.
- Notable investors include Innovate UK, Microsoft for Startups, The FSE Group, Labcorp Venture Fund, Andrew Cooper — 15 tracked in total.
- Status: Privately Held (backing).
Leadership
- Jose GalvezChief Medical Officer
- Joseph LengfellnerExecutive
- Laura HiltyChief Strategy Officer
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for IgniteData
- ·The full record, as it builds
Funding rounds
No funding rounds for IgniteData are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IgniteData
Developer of patient recruitment and real-world evidence technologies designed to streamline key clinical research processes. The company's technology transforms patient data automation for clinical trials through its cloud-based EHR-to-EDC technology, enabling clients to speed up studies, improve quality, and minimize workloads.
- Sector
- Healthcare
- HQ
- Maidenhead, United Kingdom
- Founded
- 2014
- Employees
- 41
- Website
- ignitedata.com/
- Ownership
- Privately Held (backing)
IgniteData doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IgniteData shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IgniteData in its N-PORT filings yet. We sweep new filings monthly.